CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project uses synthetic biology to create new natural product analogues for drug discovery, particularly antibiotics. By modifying existing biosynthetic pathways, the project aims to generate compounds that can combat drug-resistant infections and improve drug efficacy.
We aim to consolidate a trans-disciplinary research programme in which synthetic biology is harnessed to enable synthetic chemistry.
We will utilise this approach to expeditiously access series of previously intractable natural product analogues.There is an urgent need for the discovery and development of new drugs and in particular new antibiotics.
More than 13 million lives worldwide are currently claimed each year due to infectious diseases.
Natural products provide an unparalleled starting p…
THE UNIVERSITY COURT OF THE UNIVERSITY OF ST ANDREWS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
